Methods and compositions for therapeutic uses of a fibrin-specif

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241581, 4241811, 4241831, 4241791, 53038825, 5303881, 5303911, 5303917, 5303915, A61K 39395, C07K 1618

Patent

active

057231265

ABSTRACT:
The subject invention relates a method for the production of monoclonal antibodies. The method utilizes an immunized germfree animal. The invention also provides methods for the use of such monoclonal antibodies, and polyclonal antibodies derived from an immunized germfree animal, for in vitro and in vivo clinical diagnostics and therapeutics. Also, the subject invention provides a fibrin-specific monoclonal antibody.

REFERENCES:
patent: 5120834 (1992-06-01), Gargan et al.
patent: 5256413 (1993-10-01), Haber et al.
patent: 5487892 (1996-01-01), Gargan
Bode, C. et al., Science, 229(H715):765-767, 1985.
Vitetta, E. S. et al, Transplantation, 37(6) 535-538, 1984.
Lee, F.H. et al, Fed. Proc, 36(3):5154, 1977.
Lee, F.H. et al, Cancer Immunol Immunother, 5:201-206, 1978.
DeNardo, S.J. et al, J. Nucl Med., 29(5):899, May 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for therapeutic uses of a fibrin-specif does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for therapeutic uses of a fibrin-specif, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for therapeutic uses of a fibrin-specif will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2245518

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.